Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Total Liabilities: 2011-2025

Historic Total Liabilities for Mesa Laboratories (MLAB) over the last 15 years, with Sep 2025 value amounting to $251.9 million.

  • Mesa Laboratories' Total Liabilities fell 13.93% to $251.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $251.9 million, marking a year-over-year decrease of 13.93%. This contributed to the annual value of $273.5 million for FY2025, which is 9.25% down from last year.
  • As of Q3 2025, Mesa Laboratories' Total Liabilities stood at $251.9 million, which was down 4.32% from $263.2 million recorded in Q2 2025.
  • Mesa Laboratories' 5-year Total Liabilities high stood at $338.8 million for Q4 2023, and its period low was $195.2 million during Q1 2021.
  • Its 3-year average for Total Liabilities is $277.9 million, with a median of $273.5 million in 2025.
  • In the last 5 years, Mesa Laboratories' Total Liabilities soared by 60.60% in 2022 and then fell by 19.27% in 2024.
  • Mesa Laboratories' Total Liabilities (Quarterly) stood at $325.4 million in 2021, then declined by 15.24% to $275.8 million in 2022, then climbed by 22.85% to $338.8 million in 2023, then declined by 19.27% to $273.5 million in 2024, then decreased by 13.93% to $251.9 million in 2025.
  • Its Total Liabilities stands at $251.9 million for Q3 2025, versus $263.2 million for Q2 2025 and $273.5 million for Q1 2025.